The short answer: it should mean a licensed clinician who has the information to decide, checks what matters before prescribing, follows up after, can say no, and gains nothing by saying yes. Every company we checked says a licensed provider makes the decision. Far fewer say publicly what that provider checks first, and only one says how its clinicians are, or are not, rewarded.
What Hims said
On October 15, Hims & Hers published "Our Commitment to Independent, Clinician-Led Care", written by Brian K. Williams, MD. In its own words:
- Who decides: "An independent, licensed healthcare provider reviews it, and decides whether treatment is right for them, and if so, which one."
- Who employs clinicians: "Every clinician providing care to Hims & Hers customers is employed or contracted by an independent provider group, separate from Hims & Hers and owned and managed by licensed healthcare providers."
- What Hims does not do: "We don't make clinical decisions about any customers. We don't hire, contract with, or fire providers. And we don't incentivize providers for the number of prescriptions they write."
- Saying no: "If a provider decides treatment through the platform isn't the right fit, they can decline to treat the customer and refer them to a more appropriate care setting."
It is a clear public benchmark to compare other providers against.
One thing the statement doesn't cover is the medication itself. Hims owns the pharmacies that fill many of its customers' prescriptions. It bought Apostrophe in 2021, which gave it a fully owned pharmacy, and MedisourceRx, a California sterile compounding facility, in 2024. A company that owns the pharmacy earns on the medication as well as the visit. That says nothing about how any one clinician decides, but it is a fair question to ask every provider: who makes money when you're prescribed?
Why the question matters now
Three recent reports put "clinician-led" under a spotlight:
- CNN reported on October 15 that clinicians and eating-disorder specialists are seeing more patients with anorexia using GLP-1s, many obtained online. A Hims spokesperson told CNN that "any answer indicating current or past disordered eating triggers additional clinical questions, closer provider review, and in many cases a referral to specialty eating disorder care off our platform." A Ro spokesperson said clinicians can "request records, require a video evaluation, or order lab testing," and that patients with a history of eating disorders are directed to "seek in-person care."
- A Yale "secret shopper" study in JAMA tried to get a GLP-1 prescription from 49 websites between August and December 2025. As Healio reported, 45 of the 49 prescribed, 55.1% asked about eating disorders, 26.5% required a video visit, and 6.1% required a phone call.
- The FDA's September 18 warning letter to a compounding pharmacy, Empower Pharmacy, cited prescriptions whose required "significant difference" statements "appear to be repeated verbatim across many records, suggesting that they may be pre-generated for selection by the prescriber." The letter names no telehealth company.
What seven online prescribers say
We read each company's weight-loss pages, FAQs, and legal disclosures on October 17, 2026. Quotes are their words. "Not stated" means we looked and found nothing public, not that the company doesn't do it.
| Who decides | Eating-disorder screening | Weight verified | Labs | Video visit | Follow-up | Clinician pay | |
|---|---|---|---|---|---|---|---|
| Hims & Hers | Independent licensed provider | Yes, per statement to CNN | Not stated | Not stated | Depends on state | Yes | No incentive for prescription count (per statement) |
| Ro | Ro-affiliated provider | Yes, per statement to CNN | Not stated | Sometimes | Can be required | Monthly check-ins | Not stated |
| Mochi Health | Affiliated physicians and clinicians | Not stated | Not stated | If needed, plus follow-up labs | Yes | Video visits | Not stated |
| MedVi | OpenLoop Health clinicians | Not stated | Not stated | Not stated | Clinician "will meet" after checkout | Portal check-ins | Not stated |
| gimme.care | Licensed US provider | Not stated | Not stated | Not stated | Only in some states | Check-in before each refill | Not stated |
| Dr. B (drb.ai) | Affiliated licensed providers | Not stated | Not stated | Not stated for weight loss | If state or condition requires | Monthly AI consultations, reviewed by a provider | Not stated |
| Found | Found-affiliated provider | Evaluates "eating behavior" (2024 blog post) | Not stated | Yes (2024 blog post) | Not stated | Monthly check-ins | Not stated |
The sources, in each company's words:
- Hims & Hers. Its FAQ: "Depending on your state, treatment may be determined without a video visit," and "Dosage and titration vary based on provider discretion." Its statement: "As care continues, providers adjust doses, respond to side effects, and change medications when they determine it's needed."
- Ro. Its program guide: "A Ro-affiliated provider will review your responses and determine if you're a fit for GLP-1 treatment," and "Sometimes, they may order a metabolic lab test." Membership includes "monthly check-ins and unlimited (free!) messaging."
- Mochi Health. Its homepage: "An in-depth video visit," "If needed, we'll order labs," and "Follow-up labs keep your plan on track." Its disclosure: "All professional medical services are provided by licensed physicians and clinicians affiliated with independently owned and operated professional practices."
- MedVi. Its homepage: OpenLoop Health "has established exclusionary criteria," "an OpenLoop Health clinician will meet with an individual after checkout to determine if they qualify for a prescription," and "OpenLoop Health clinicians retain the decision to prescribe compounded GLP-1s to patients."
- gimme.care. Its homepage: "A licensed US provider will review your answers and determine if you're eligible," refills ship "every 28 days after a short check-in," and "In most states, treatment can begin without a video visit."
- Dr. B. Its homepage: "Patients take monthly AI consultations that are reviewed by licensed medical providers independently or via video visit." Its disclosure says Dr. B does not "employ or in any way supervise the clinicians providing medical care."
- Found. Its homepage: "the ultimate decision as to whether a patient is medically eligible for a medication rests with the provider," and "Check-ins continue monthly." A 2024 Found blog post: "Eligibility for a GLP-1 is based on a thorough evaluation of medical history, eating behavior, lab work, and insurance coverage."
What "clinician-led" should mean
Read side by side, these statements suggest five tests:
- The clinician can say no, and nothing rewards saying yes. Hims states this about prescription volume. Ask every provider the same.
- The clinician checks what a form can't. The CEO of the American Telemedicine Association said in a statement to CNN that "a questionnaire that can be gamed with false information is a clinical governance failure, not a telehealth-specific one."
- The decision is written for you, not selected from a menu.
- Care continues. Dose changes, side effects, and stopping run through a clinician, not an automatic refill.
- You can see who profits from the medication. If the company also owns the pharmacy, it earns on every fill. Ask, and ask whether you can compare pharmacy prices yourself.
Questions you can ask any provider
Copy these into your Notes app before you sign up. Short, clear answers are a good sign.
- Who makes the decision, and what are their credentials?
- What do you check before prescribing: eating-disorder history, weight, labs?
- When would you require a video or phone visit?
- How are your clinicians paid? Does anyone earn more if I'm approved?
- What happens to my fee if the clinician says no?
- Who adjusts my dose, and how often will a clinician review my care?
- Can I choose my pharmacy?
- Do you own the pharmacy that fills my prescription? How much of what I pay for the medication do you keep?
Where Temi fits
Here is how Temi answers the questions our own policies cover. A licensed physician reviews every request. We charge for the clinical review, not for prescribing, so a decision not to prescribe is part of the service. Temi owns no pharmacy: you choose the pharmacy that fills your prescription, and when one of our partner pharmacies fills it, our markup on the medication is capped at 15% and you see each pharmacy's price before you choose. A new prescription review is $79, and everyday refills are $15 per renewal, both $0 with Temi Care ($449 a year). We serve patients in Arizona, California, Colorado, Delaware, Florida, Michigan, Missouri, New York, North Carolina, Ohio, Pennsylvania, Texas, and Wisconsin.
Company pages were checked on October 17, 2026. Policies change; check each provider's current pages before you decide.




